Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Genomic Health Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Genomic Health Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Epic Sciences Raises USD40 Million in Series D Venture Financing 12
InVitae Raises USD120 Million in Series F Venture Financing 14
Invitae Raises US$40 Million In Series E Financing 16
Partnerships 17
Genomic Health Enters into Licensing Agreement with Biocartis 17
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 18
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 19
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 21
Genomic Health and Epic Sciences Enter into Distribution Agreement 22
Philips Electronics Enters into Agreement with Genomic Health 23
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 24
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 25
Equity Offering 26
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 26
Genomic Health Inc – Key Competitors 27
Genomic Health Inc – Key Employees 28
Genomic Health Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress 30
Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 32
May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress 34
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 36
Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results 38
Aug 02, 2016: Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance 40
May 04, 2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results 42
Feb 10, 2016: Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results 44
Jan 08, 2016: Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations 46
Product News 47
Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types 47
May 30, 2017: Genomic Health Announces Presentation of Eight Oncotype DX Studies at the 2017 American Society of Clinical Oncology Annual Meeting Reinforcing Unique Impact Across Cancer Types 49
Sep 28, 2016: Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress 52
03/11/2016: Genomic Health Announces Five-year Outcomes from International ‘PlanB’ Study Demonstrating the Clinical Utility of Oncotype DX in Node-positive and High-risk Node-negative Breast Cancer 55
03/09/2016: German National Cancer Guidelines Distinguish Oncotype DX as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence 57
03/01/2016: Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX 58
01/11/2016: Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
Genomic Health Inc, Medical Equipment, Key Facts, 2016 2
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Genomic Health Inc, Deals By Market, 2011 to YTD 2017 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Epic Sciences Raises USD40 Million in Series D Venture Financing 12
InVitae Raises USD120 Million in Series F Venture Financing 14
Invitae Raises US$40 Million In Series E Financing 16
Genomic Health Enters into Licensing Agreement with Biocartis 17
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 18
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 19
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 21
Genomic Health and Epic Sciences Enter into Distribution Agreement 22
Philips Electronics Enters into Agreement with Genomic Health 23
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 24
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 25
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 26
Genomic Health Inc, Key Competitors 27
Genomic Health Inc, Key Employees 28
Genomic Health Inc, Other Locations 29
Genomic Health Inc, Subsidiaries 29